Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-3170
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins ; volume:19 ; number:4 ; day:17 ; month:3 ; year:2017 ; pages:1-9 ; date:4.2017
Current cardiology reports ; 19, Heft 4 (17.3.2017), 1-9, 4.2017
- Creator
-
Eggers, K. M.
- Contributor
-
Lindahl, B.
SpringerLink (Online service)
- DOI
-
10.1007/s11886-017-0840-3
- URN
-
urn:nbn:de:101:1-2018082408511135428109
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eggers, K. M.
- Lindahl, B.
- SpringerLink (Online service)
Other Objects (12)
Biomarkers for Non-Invasive Stratification of Coronary Artery Disease and Prognostic Impact on Long-Term Survival in Patients with Stable Coronary Heart Disease
Acute Coronary Syndromes in Women
Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile
Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes
Dropping risk stratification with subsequent treatment-risk paradox in non ST elevation acute coronary syndromes: a clinical audit in Iraq
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
RNA biomarkers for stratification of pancreatic ductal adenocarcinoma
Risk Stratification of Patients Undergoing Percutaneous Coronary Intervention
Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease
Prediction of acute coronary syndromes by urinary proteome analysis
Metabolism of ticagrelor in patients with acute coronary syndromes
Biomarkers for Non-Invasive Stratification of Coronary Artery Disease and Prognostic Impact on Long-Term Survival in Patients with Stable Coronary Heart Disease
Acute Coronary Syndromes in Women
Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile
Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes
Dropping risk stratification with subsequent treatment-risk paradox in non ST elevation acute coronary syndromes: a clinical audit in Iraq
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
RNA biomarkers for stratification of pancreatic ductal adenocarcinoma
Risk Stratification of Patients Undergoing Percutaneous Coronary Intervention
Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease
Prediction of acute coronary syndromes by urinary proteome analysis
Metabolism of ticagrelor in patients with acute coronary syndromes
Biomarkers for Non-Invasive Stratification of Coronary Artery Disease and Prognostic Impact on Long-Term Survival in Patients with Stable Coronary Heart Disease
Acute Coronary Syndromes in Women
Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile
Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes
Dropping risk stratification with subsequent treatment-risk paradox in non ST elevation acute coronary syndromes: a clinical audit in Iraq
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
RNA biomarkers for stratification of pancreatic ductal adenocarcinoma
Risk Stratification of Patients Undergoing Percutaneous Coronary Intervention
Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease
Prediction of acute coronary syndromes by urinary proteome analysis